Randomized Trial for Pharmacogenomics-based Proton Pump Inhibitor Therapy in Children

Summary

Proton pump inhibitors are administered to children as off-label use in Japan. The purpose of this study is to evaluate the effects of CYP2C19 genotypes on pharmacokinetic /pharmacodynamic profiles of PPI in children. The results will provide the beneficial information for the individualized medicine of PPI in children.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications